Atlas Trials

A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT01076504 · COMPLETED

Trial details

NCT number
NCT01076504
Sponsor
SCRI Development Innovations, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Extensive-Stage Small Cell Lung Cancer
Start date
2009-12-01
Primary completion
2012-03-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.